CP FINAL-- Pre-eclampsia

Embed Size (px)

Citation preview

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    1/44

    Bukidnon State University

    COLLEGE OF NURSING

    Malaybalay City

    A Case Presentation on

    PRE - ECLAMPSIA

    As Part of the Requirements in NCM 102

    CARE OF MOTHER, CHILD, FAMILY AND POPULATION GROUP AT-RISK OR

    WITH PROBLEMS

    Submitted by:

    Alberto, Dani Michaela B.

    Antivo, Jovelyn L.

    Auguis, Fe B.

    Biao, Kathlene Joy O.

    Casite, Nielmark L.

    Gomez, Junfelm M.

    Jacutin, Sushmita Ann J.

    Jamis, Kieth G.

    Rellita, Jezza S.

    Submitted to:

    Hazel Paloma-Agbayani RN, MN

    Clinical Instuctor

    March 11-12, 2013

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    2/44

    TABLE OF CONTENTS

    I. Objectives

    II. Introduction

    III. Assessment

    a. Demographic Data

    b. History of Past illness

    c. History of Present illness

    d. Systems Involved

    IV. Anatomy and Physiology

    V. Pathophysiology

    VI. Actual Treatment

    a. Laboratory Exam

    b. Drug Study

    VII. Ideal Treatment

    a. Treatment

    b. Surgical Management

    VIII. Nursing Care Plan

    a. Actual Nursing Care Plan

    b. Ideal Nursing Care Plan

    IX. Discharge Plans

    X. Doctors Order

    XI. Prognosis

    XII. Research Update

    XII. References

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    3/44

    I. OBJECTIVES

    General Objectives:

    During our 3-hour discussion, we will be able to present our case about Pre-

    Eclampsia accordingly. This case presentation seeks to share and enhance our knowledge

    with regards to the patients general health condition and her needs. This also seeks to

    comprehend our skills through application of several nursing interventions and medical

    management. Furthermore, this case presentation intends to improve the students attitude

    by conveying open-mindedness and utilizing therapeutic communication all throughout

    the activity.

    Specific Objectives:

    During our 3-hour discussion, we aim to achieve the following objectives with

    regards to Pre-Eclampsia:

    1. Present a thorough general health assessment of the client which includes physical

    assessment.

    2. Correctly provide concise and complete information with regards to the patients

    condition.

    3. Discuss an overview of Anatomy and Physiology of the Cardiovascular System,

    Exocrine System, Endocrine System, Integumentary System and Reproductive

    System.

    4. Efficiently provide appropriate and proper nursing diagnosis in line with the

    clients medical condition.

    5. Identify and discuss the ideal and actual nursing care plans for the different

    problems identified.

    6. Skilfully formulate appropriate nursing interventions according to the standards of

    nursing practice.

    7. Impart the outcome of the nursing interventions.

    8. Convey the significance of clients response to the rendered nursing interventions.

    9. Discuss the health teachings intended for the patient.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    4/44

    II. INTRODUCTION

    Pregnancy-induced hypertension (PIH) is a condition in which vasospasm occurs

    during pregnancy in both small and large arteries. Signs of hypertension, proteinuria, and

    edema develop. It is unique to pregnancy and occurs in 5% to 7% of pregnancies (Bailis

    & Witter, 2007). Despite years of research, the cause of the disorder is still unkonown

    although it is highly correlated with the antiphospholipid syndrome or the presence of

    antiphospholipid antibodies (Clark, Silver, & Branch, 2007). Originally it was called

    toxemia because researchers pictured a toxin of some kind being produced by a woman in

    response to the foreign protein of the growing fetus, the toxin leading to the typical

    symptoms.

    A condition separate from chronic hypertension, PIH tends to occur most

    frequently in women of color or with a multiple pregnancy, primiparas younger than 20

    years or older than 40 years, women from low socioeconomic backgrounds, those who

    have had five or more pregnancies, those who have hydramnios, or those who have an

    underlying disease such as heart disease, diabetes, and essential hypertension

    PIH is classified as gestational hypertension, mild pre-eclampsia, severe pre-

    eclampsia, and eclampsia, depending on how far development of the syndrome has

    advanced.

    A woman has passed from mild to severe pre-eclampsia when her blood pressure

    rises to 160 mm Hg systolic and 110 mm Hg diastolic or above on at least two occasions

    6 hours apart at bed rest or her diastolic pressure is 30 mm Hg above her prepregnancy

    level. Marked proteinuria, 3+ or 4+ on a random urine sample or more than 5g in a 24-

    hour sample, and extensive edema are also present.

    With severe pre-eclampsia, the extreme edema is most readily palpated over bony

    surfaces, such as over the tibia on the anterior leg, the ulnar surface of the forearm, and

    the cheekbones, where the sponginess of fluid-filled tissue can be palpated against bone.

    In addition, symptoms of preeclampsia can include:

    Rapid weight gain caused by a significant increase in bodily fluid

    Abdominal pain

    Severe headaches

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    5/44

    A change in reflexes

    Reduced output of urine or no urine

    Dizziness

    Excessive vomiting and nausea

    The only real cure for preeclampsia and eclampsia is the birth of the baby. Severe

    preeclampsia (blood pressure greater than 160/110) that occurs after 20 weeks of

    gestation in a woman who did not have hypertension before; and/or having a small

    amount of protein in the urine can be managed with careful hospital or in-home

    observation along with activity restriction.

    The group chose the case for the reason that they wanted to show the readers the

    process on how pre-eclampsia occurs and for them to fully understand and be reminded

    on one of the complications associated with pregnancy.

    III. ASSESSMENT

    A. Demographic Data

    Name: Mrs. Pre Eclampsia Sex: Female Age: 27 years old

    Address: Purok-4 Kapitan Bayong, Impasug-ong Bukidnon

    Date of Birth: July 25, 1985 Place of Birth: Lumbayao, Valencia City

    Nationality: Filipino Civil Status: Married

    Occupation: Housewife Religion: Roman Catholic

    Dependents: John Harley 9 Year Old

    Christian 7 Year Old

    Lyka 4 Year Old

    Charlyn and Charmaine 1 Month & 11 days

    Usual Source of Medical Care: Health Center

    Food Allergy: No known food allergy

    Drug Allergy: No known drug allergy

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    6/44

    Admitting Diagnosis: Pregnancy Uterine Full Term, Cephalic/Breech Multiple

    Pregnancy G4P3 (3003)

    Final Diagnosis:

    1. G4P5 (4005)

    2. Pregnancy Uterine Delivered Term Live Births Baby Girl I & II in Breech-

    Cephalic Presentation via Low Segment Transverse Caesarean Section for Multi

    fetal Pregnancy. Severe Pre-eclampsia. Baby girl I birth weight- 2.2 Kilogram,

    Baby girl II birth weight-2.4 Kilogram.

    Surgical Procedure: Low Segment Transverse Caesarean Section with Bilateral

    Tubal Ligation

    Date and Time of Operation: January 28, 2013 / 2:00 pm

    Attending Physician: Gaye Emerald Oribello M.D

    Chief Complaint: Labor pains

    Date of Admission: January 27, 2013

    Time of Admission: 4:50PM

    Vital signs upon admission: Temp: 36.4C

    BP: 120/80mmHg

    PR: 81 bpm

    RR: 21 cpm

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    7/44

    B. History of Past Illness

    Mrs. Pre-eclampsia completed her immunization during childhood. She

    experienced mumps when she was a child. She also experienced diarrhea, fever, cough,

    colds and she self-medicated it with over the counter medications like paracetamol and

    other medications before she became pregnant. When she was 16 year old she was

    admitted to the hospital due to accidental intake of kerosene. She stayed at the hospital

    for almost a week and then recovered. She had completed all her immunizations and

    including two shots of tetanus toxoid during her prenatal visits. She had no known food

    and drug allergies.

    C. History of Present Illness

    Seven hours prior to admission, thepatient experienced labor pains. Four hours

    after, the midwife advised her to deliver the baby in the hospital because she had high

    blood pressure. The midwife called an ambulance to fetch her in their place. The patient

    arrived at Bukidnon Provincial Medical Center three hours after. She was admitted for

    further evaluation and tests. She manifested some problems such as headache that lasted

    for a minute and pain in the nape. Her Blood Pressure rose up to 180/120 mm Hg. The

    contractions lasted for about a minute until it became frequent. After being seen and

    examined by her attending physician, high blood pressure and pitting edema prior to her

    admission were noted.

    Environmental Factors

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    8/44

    Mrs. Pre-Eclampsia resides at Purok-4 Kapitan Bayong, Impasug-ong Bukidnon.

    The family is composed of the parents and their three children respectively. Their house

    was made of bamboo walls, wooden floors and cellophane roof. The house is divided into

    two divisions, kitchen and room. The house is located near a slope. They were able to

    clean the house on a regular basis. They had a common source of water and comfort

    rooms which they shared with neighbors. The location of their house is not easily

    accessible to hospitals and also kilometers away from the health center.

    Socio-Economic and Cultural Factors

    Mrs. Pre-eclampsia is a plain housewife and her husband is a packer in a factory.

    She hasnt pursued her Secondary level due to financial constraints.

    Mrs. Pre-eclampsia was raised as a Roman Catholic where she learned her

    religious values but also, she still believes in superstitious beliefs. When it comes to

    health matters, she uses herbal medicines to treat any member of the family who has an

    ailment, but when serious matters arise she still refer it to health care providers for help.

    D. Systems Involved

    Cardiovascular/Circulatory System

    Objective Data:

    Temperature: 37C Radial pulse: 88bpm

    Blood Pressure: 160/100mmHg Edema: Pitting

    Nail bed color : Pink Capillary refill: 1 second

    Subjective Data:

    Comments: The patient stated

    Remarks: Patient has normal heart sounds and rhythm. Patient

    has high blood pressure accompanied by pitting edema.

    Nursing Diagnosis:

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    9/44

    Integumentary System

    Elimination

    Objective Data:

    Skin: Warm and moist Hair: Even distribution of hair

    Turgor: Edema Nails: Clean nails and

    pinkish in color

    Temperature: 37C Capillary refill: 1 second

    Subjective Data:

    Comments: The patient stated

    Objective Data:

    Mobility and Dexterity: Ambulatory Abdomen: Soft

    Edema: Yes, Lower extremities

    Urine Color:

    Subjective Data:

    Comments: The patient stated

    Remarks: Patient has normal skin color, temperature, hair

    distribution and nails. Patient is noted of pitting edema withdisturbed skin integrity in abdomen.

    Nursing Diagnosis:

    Remarks:

    Nursing Diagnosis:

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    10/44

    Metabolic/Nutrition

    Physical Assessment

    The Cephalocaudal assessment was done last February 25, 2013

    1. Skin

    Brown skin in areas exposed to the sun

    When pinched, skin readily springs back to previous state

    2. Head

    Absence of nodules or masses

    Symmetric facial features and movements

    Evenly distributed black hair

    Objective Data:

    General Appearance: 37C

    Blood Pressure: 160/100mmHg

    Radial pulse: 88bpm

    Nail bed color : Pink

    Capillary refill: 1 second

    Edema: Pitting

    Subjective Data:

    Comments: The patient stated

    Remarks: Patient has high blood pressure accompanied by pitting

    edema.

    Nursing Diagnosis:

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    11/44

    3. Cardiovascular

    Blood pressure of 130/90 mmHg

    Pulse rate of 90 bpm

    4. Gastrointestinal/Abdomen

    Striae present at hypogastric and iliac regions

    Linea nigra present

    Presence of surgical incision

    5. Reproductive

    Regular menstrual cycle

    Gravida 4 Para 5

    IV. ANATOMY AND PHYSIOLOGY

    Cardiovascular System

    1. Heart

    The heart is located within the bony thorax and is flanked on each side by the

    lungs approximately. The apex is directed toward the left hip and rests on the diaphragm,

    approximately at the level of the fifth intercostal space. Its base, from which the great

    vessels of the body emerge, points toward the right shoulder and lies beneath the second

    rib. The heart is divided into four chambers namely the two atria and two ventricles

    separated by the septums. There are three types of blood vessels: the arteries, the veins

    and the capillaries. An artery is a vessel that carries blood away from the heart and carries

    oxygenated blood. Small arteries are called arterioles. Veins, on the other hand are

    vessels that carries blood toward the heart and contains deoxygenated blood. Small veins

    are called venules. Lastly, capillaries are microscopic vessels that carry blood from small

    arteries to small veins (arterioles to venules) and back to the heart.

    The walls of the blood vessels, the arteries and veins have three main layers:

    tunica adventitia, tunica media and tunica intima. Tunica adventitia which is a fibrous

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    12/44

    type of vessel is a connective tissue that helps hold vessels open and prevents tearing of

    the vessel wall during body movement. Tunica media permits changes of the blood

    vessel diameter. It allows the constriction and dilation of the vessels. Last but not the

    least is the tunica intima. Tunica intima, which in Latin means innercoat, is made up of

    endothelium that is continuous with the endothelium that lines the heart. In arteries, it

    provides a smooth lining. However in veins it maintains the one-way flow of the blood.

    The endothelium, which makes up the thin coat of the capillary, is important because the

    thinness of the capillary wall allows the exchange of materials between the blood plasma

    and the interstitial fluid of the surrounding tissues.

    There are two circulatory routes of blood as it flows through the blood vessels: the

    systemic and the pulmonary circulation. In systemic circulation, blood flows from the left

    ventricle of the heart through blood vessels to all parts of the body (except gas exchange

    tissues of lungs) and back to the atrium. In pulmonary circulation on the other hand,

    venous blood moves from the right atrium to right ventricle to pulmonary artery to lung

    arterioles and capillaries where gases exchange; oxygenated blood returns to the left

    atrium via pulmonary veins; from left atrium, blood enters the left ventricle.

    2. Vasomotor Control Mechanism

    Blood distribution patterns, as well as BP can be influenced by factors that control

    changes in the diameter of arterioles. Such factor might be said to constitute the

    vasomotor control mechanism. Like most physiological control mechanisms, it consists

    of many parts. An area in the medulla called vasomotor center/ vasoconstrictor center

    will, when stimulated initiate an impulse outflow via sympathetic fibers that ends in

    smooth muscle surrounding resistance vessels, arterioles, and veins of the blood

    reservoir causing their constriction thus the vasomotor control mechanism plays an

    important role both in the maintenance of the general BP and in the distribution of blood

    to areas of special need.

    3. Venous Return of the Blood

    Venous return refers to the amount of blood that is returned to the heart by the

    way of veins. Various factors influence venous return, including the operation of venous

    pumps that maintains the pressure gradients necessary to keep blood moving into the

    central veins and from there the atria of the heart. Changes in the total volume of blood

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    13/44

    vessels can also alter the venous return. The return of venous blood to the heart can be

    influenced by the factors that change the total volume of blood in the circulatory

    pathway. Stated simply, the more the total volume of blood, the greater the volume of

    blood returned to the heart. The mechanism that change the total blood volume most

    quickly, making them most useful in maintaining constancy of blood flow, are those that

    cause water to quickly move into the plasma or out of the plasma.

    Most of the mechanisms that accomplish such changes in plasma volume operate

    by altering the bodys retention of the water. The primary mechanisms for altering the

    water retention in the body are the endocrine reflexes in the body. One is the ADH

    mechanism is released in the neurohypophysis and acts on the kidneys in a way that

    reduces the amount of water lost by the body. ADH does this by increasing the amount of

    water that kidneys reabsorb from urine before the urine is excreted from the body. The

    more ADH is secreted, the more water will be reabsorbed into the blood, and the greater

    the blood plasma volume will become.

    Another mechanism that changes the blood plasma volume is the

    renninangiotensin mechanism of aldosterone secretion. Renin is an enzyme that is

    released when the blood pressure in the kidney is low. Renin triggers a series of events

    that leads to the secretion of aldosterone. Aldosterone promotes sodium retention by the

    kidney, which in turn stimulates the osmotic flow of water to the kidney tubules back into

    the blood plasma- but only when ADH is present to permit the movement of water. Thus,

    low blood pressure increases the secretion of aldosterone, which in turn stimulates the

    retention of water and thus an increase in blood volume. Another effect of

    reninangiotensin is the vasoconstriction of blood vessels caused by an intermediate

    compound called angiotensin II. This complements the volume-increasing effects of the

    mechanism and thus also promotes an increase in overall blood flow. Precision of blood

    volume control contributes to the precision in controlling venous return, which in return

    yields to the precise overall control of blood circulation

    Exocrine System

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    14/44

    The exocrine systems main function is to regulate the volume and composition of

    body fluids and excrete unwanted materials, but it is not the only system in the body that

    is able to excrete unnecessary substances.

    1. Kidneys

    The average-sized kidney measures around 12cm long, 6 cm wide, and 3cm thick.

    The left kidney is often larger than the right. The kidneys are highly vascular organs.

    Approximately, one-fifth of the blood pumped from the heart goes to the kidneys. The

    kidneys process blood plasma and form urine from waste to be excreted and removed

    from the body. These functions are vital because they maintain the homeostatic balance

    of the body. The kidneys maintain the fluid-electrolyte and acid-base balance. In

    addition, they also influence the rate of secretion of the hormones ADH and aldosterone.

    Microscopic functional units called nephrons make up the bulk of the kidney.

    The nephron is uniquely suited to its function of blood plasma processing and urine

    function. A nephron contains certain structures in which fluid flows through them and

    they are as follows: renal corpuscle, Bowmans capsule, proximal convulted tubule,

    Loop of Henle, distal convoluted tubule and the collecting tube. The Bowmans capsule

    is a cup-shaped mouth of a nephron. It is usually formed by two layers of epithelial cells.

    Fluids, electrolytes and waste products that pass through the porous glomerular

    capillaries and enter the space that constitute the glomerular filtrate, which will be

    processed in the nephron to form urine. The Glomerulus is the bodys well-known

    capillary network and is surely one of the most important ones for survival. Glomerulus

    and Bowmans capsule together are called renal corpuscle. The permeability of the

    glomerular endothelium increases sufficiently to allow plasma proteins to filter out into

    the capsule.

    Endocrine System

    The endocrine system performs their regulatory functions by means of chemical

    messenger sent to specific cells. The endocrine glands secrete their products, hormones,

    directly into the blood. There are two classifications of hormones: steroid hormones and

    non-steroid hormones. The steroid hormones which are manufactured by the endocrine

    cells from cholesterol, is an important lipid in the human body. Non-steroid hormones are

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    15/44

    synthesized primarily from amino acids rather from the cholesterol. Non-steroid

    hormones are further subdivided into two: protein hormones and glycoprotein hormones.

    1. Aldosterone

    Its primary function is the maintenance of the sodium homeostasis in the blood by

    increasing the sodium reabsorption in the kidneys. It is secreted from the adrenal cortex;

    it triggers the release of ADH which results to the conservation of water by the kidney.

    Aldosterone secretion is controlled by the rennin- angiotensin mechanism.

    2. Anti-diuretic hormone (ADH)

    It is secreted in the neurohypophysis (posterior pituitary); it literally opposes the

    formation and production of a large urine volume. It helps the body to retain and

    conserve water from the tubules of the kidney and returned to the blood.

    Integumentary System

    Also called the integument which simply means covering, the skin is much

    more than an external body covering. It is absolutely essential because it keeps water and

    other molecules in the body. The skin has many functions; most, but not all, are

    protective. It insulates and cushions the deeper body organs and protects the entire body

    from mechanical damage, thermal damage, ultraviolet radiation, and bacteria. The

    uppermost layer of the skin is full of keratin and cornified in order to prevent water loss

    from the body surface.

    The skin is composed of two kinds of tissue. The outer epidermis is made up of

    stratified squamous epithelium that is capable of keratinizing. The underlying dermis is

    made up of dense connective tissue. Deep to the dermis is the subcutaneous tissue which

    anchors the skin to underlying organs. Subcutaneous tissue serves as a shock absorber

    and insulates the deeper tissues from extreme temperature changes occurring outside the

    body.

    Reproductive System

    The female reproductive system produces gametes may unite with a male gamete

    to form the first cell of the offspring. The female reproductive system also provides

    protection and nutrition to the developing offspring. Conception, the fertilization of an

    egg by a sperm, normally occurs in the fallopian tubes. The next step for the fertilized

    http://www.webmd.com/baby/guide/understanding-conceptionhttp://www.webmd.com/baby/guide/understanding-conception
  • 7/28/2019 CP FINAL-- Pre-eclampsia

    16/44

    egg is to implant into the walls of the uterus, beginning the initial stages ofpregnancy. If

    fertilization and/or implantation does not take place, the system is designed to

    menstruate. In addition, the female reproductive system produces female sex hormonesthat maintain the reproductive cycle.

    The female reproductive anatomy includes parts inside and outside the body. The

    function of the external female reproductive structures (the genitals) is twofold: To

    enable sperm to enter the body and to protect the internal genital organs from infectious

    organisms.

    The main external structures of the female reproductive system include:

    Labia majora: The labia majora enclose and protect the other external

    reproductive organs

    Labia minora: The labia minora lie just inside the labia majora, and surround theopenings to the vagina and urethra.

    Bartholin's glands: These glands are located beside the vaginal opening and

    produce a fluid (mucus) secretion.

    Clitoris: The two labia minora meet at the clitoris, a small, sensitive protrusion

    that is comparable to thepenis in males.

    Mons Pubis: A pad of adipose tissue located over the symphisis pubis, the pelvic

    bone joint. Its purpose is to protect the junction of the pubic bone from trauma.

    Vestibule: Flattened smooth surface inside the labia.

    The internal reproductive organs in the female include:

    Vagina: The vagina is a canal that joins the cervix to the outside of the body. It

    also is known as the birth canal.

    Uterus : The uterus is a hollow, pear-shaped organ that is the home to a

    developing fetus. The uterus is divided into two parts: the cervix, which is the

    lower part that opens into the vagina, and the main body of the uterus, called the

    corpus. The corpus can easily expand to hold a developing baby.

    http://www.webmd.com/baby/default.htmhttp://women.webmd.com/picture-of-the-vaginahttp://men.webmd.com/picture-of-the-penishttp://www.webmd.com/baby/guide/your-pregnancy-week-by-week-weeks-1-4http://www.webmd.com/baby/default.htmhttp://women.webmd.com/picture-of-the-vaginahttp://men.webmd.com/picture-of-the-penishttp://www.webmd.com/baby/guide/your-pregnancy-week-by-week-weeks-1-4
  • 7/28/2019 CP FINAL-- Pre-eclampsia

    17/44

    Ovaries: The ovaries are small, oval-shaped glands that are located on either side

    of the uterus. The ovaries produce eggs and hormones.

    Fallopian tubes: These are narrow tubes that are attached to the upper part of the

    uterus and serve as tunnels for the ova to travel from the ovaries to the uterus.

    Conception, the fertilization of an egg by a sperm, normally occurs in the

    fallopian tubes. The fertilized egg then moves to the uterus, where it implants into

    the lining of the uterine wall.

    During the last few weeks of pregnancy, estrogen reaches their highest levels in

    the mothers blood. This has two important consequences: it causes the myometrium

    to form abundant oxytocin receptors and it interferes with progesterones quieting

    influence on the uterine muscle. As a result, weak and irregular uterine contractions

    occur. These contractions, called Braxton Hicks contractions. As birth nears, two

    more chemical signals cooperate to convert these false labor pains into true labor.

    Certain cells of the fetus begin to produce oxytocin, which in turn stimulates the

    placenta to release prostaglandins. Both hormones stimulate more frequent and

    powerful contractions of the uterus. The combined effects of the rising levels of

    oxytocin and prostaglandins initiate the rhythmic expulsive contractions of true labor.

    Once the hypothalamus is involved, a positive feedback mechanism is propelled intoaction: stronger contraction cause the release of more oxytocin, which causes even

    more vigorous contractions, forcing the baby ever deeper into the mothers pelvis.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    18/44

    V. PATHOPHYSIOLOGY

    Pre -

    Predisposing factors:

    Family history

    of Pre

    Eclampsia

    Socioeconomic

    status

    Precipitating

    factors:

    Multiple

    gestation

    Labor

    Vasospasm

    Reduced blood supply to

    Vascular Kidney Effects Interstitial Placenta

    Vasoconstricti

    Poor organ

    perfusion

    IncreasedBlood Pressure

    Decreased

    Glomeruli

    filtration rate &

    increased

    permeability of

    Increased serumblood urea nitrogen,

    uric acid and

    Decreased

    urine output

    Diffusion of fluid

    from bloodstream

    into interstitial

    Edema

    Poor placental

    perfusion

    Reduced fetal

    nutrient and

    Oxygen supply

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    19/44

    VI. ACTUAL TREATMENT OR MANAGEMENT

    A. Laboratory and Diagnostic Exams

    January

    23,2013

    Ultrasound Twin, live, intrauterine pregnancy as described.

    Non-biometric parameters and suggestive of

    pulmonary maturity but fetus is not yet term.

    Single anterochondal placenta grade II.

    Normohydramnios.

    No growth discorday noted.

    Frank breech presentation

    -36 weeks and 4 days AOG

    -Single nuchal cord seen

    Cephalic presentation

    -36 weeks and 3 days AOG-No nuchal cord

    Single placenta is antherofundal in location,

    grade II maturity.

    January 27,

    2013

    Physical exam General status:

    - Conscious, coherent, cooperative.

    Abdomen:

    -L1-breech L3-cephalic L4-engaged

    Pelvic exam:

    -Vagina-parallel, uterus-globular.

    Date

    ordered

    Laboratory and

    diagnostic

    Results Normal findings Significance

    01/27/13 CBC

    White cell count

    17,900

    5,000-10,000/mm3

    Hemoglobin 11.2 11.7-14.5 g/dl

    Hematocrit 34.5 34.1-44.3 volumes

    %

    Platelet 364,000 174,000-390,000Segmenters 89 43.4-76.2

    Lymphocytes 11 17.4-46.2

    Proteinuria

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    20/44

    Cervical length/dilatation/effacement:

    -8cm, STO, cephalic, 1st twin, 80% effaced.

    Cervical position:

    -anterior

    Presentation:

    -cephalic Membranes:

    -intact

    January 27,

    2013

    Clinical

    Pelvimetry

    Adequate

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    21/44

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    22/44

    B. Drug Study

    PO Medications

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    23/44

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    24/44

    PO Medications

    POSTOPERATIVE DRUGS

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    25/44

    Name ofdrug

    Generic

    (Brand)

    Classification Dose/Frequency/

    Route

    Mechanism ofaction

    Indication Contraindication Nursing precaution

    Oxytocin Hormone

    Oxytoxic

    35 u and 20

    u

    Synthetic form of

    an endogenous

    hormone producedin thehypothalamus and

    stored in posteriorpituitary;

    stimulates the

    uterus, especiallythe gravid uterus

    just before theparturition, and

    causes

    myoepithelium ofthe lacteal glands

    to contract, whichresults in milk

    ejection inlactating women.

    Lactation deficiency

    Antepartum; toinitiate or improveuterine contraction s

    to achieve earlyvaginal delivery;

    stimulation or

    reinforcement oflabor in selected

    cases of uterineinertia; management

    of inevitable or

    incomplete abortion;second trimester

    abortion.

    Postpartum;To pro produce

    uterine contraction

    during the third stageof labor and to

    control postpartumbleeding or

    hemorrhage.

    Contraindicated

    with significant

    cephalopelvicdisproportion,unfavorable fetal

    positions orpresentations,

    obstetric

    emergencies thatfavor surgical

    intervention,prolonged use in

    severe toxemia,

    uterine inertia,hypertonic uterine

    patterns,induction or

    augmentation oflabor when

    vaginal delivery

    iscontraindicated,

    previous cesareansection,

    pregnancy.

    Use cautiously with

    renal impairment.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    26/44

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    27/44

    Name ofdrug

    Generic(Brand)

    Classification Dose/Frequency/

    Route

    Mechanism ofaction

    Indication Contraindication Nursing precaution

    Ketorolac Analgesic 30mg IVTTQ8 x 24

    Unknown; mayinhibit

    prostaglandin

    synthesis.

    Short-termmanagement of pain

    Contraindicatedin patients

    hypersensitive to

    drug and in thosewith a history of

    syndrome ofnasal polyps,

    angioedema,bronhospastic

    reactivity, or

    allergic reactionto aspirin or other

    NSAIDS;in thosewith advance

    renal impairment;

    and in those atrisk for renal

    failure as a resultof volume

    depletion. Alsocontraindicated in

    patients with a

    with suspected orconfirmed

    cerebrovascularbleeding,

    hemorrhage

    diathesis, andincomplete

    homeostasis.Not

    recommended forintrathecal or

    epidural

    administrationbecause of its

    alcohol content.

    Use cautiously inwomen, patients in

    the perioperative

    period; and patientswith hepatic or

    renal impairment,history of serious

    GI events of pepticulcer disease,

    cardiac

    decompensation,Hypertension or

    coagulationdisorders.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    28/44

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    29/44

    Name ofdrug

    Generic

    (Brand)

    Classification Dose/Frequency/

    Route

    Mechanism ofaction

    Indication Contraindication Nursing precaution

    Hydralazine Antihypertensive,

    vasodilator(peripheral)

    10mg

    IVTT

    Acts directly

    on vascular

    smoothmuscle tocause

    vasodilatation,primarily

    arteriolar,

    decreasingreticular

    resistance;maintenance

    or increases

    renal orcerebral blood

    flow.

    Essential

    hypertension

    alone or incombinationwith other

    drugs.

    Reducing

    after load inthe treatment

    of heartfailure,

    severe aortic

    insufficiency,and after

    valvereplacement

    (doses up to800mg tid)

    Contraindicated

    with

    hypersensitivityto hydralazine,tartrazine (in

    100 mg tabletsmarketed as

    apresoline);

    CAD, mitralvalvular

    rheumatic heartdisease

    (implicated with

    MI).

    Use cautiously with CVAs;increase

    intracranial pressure(drug-induced BP

    decrease increases risk of cerebralischemia);severe hypertension withuremia; advanced renal damage; slow

    acytelators (higher plasma levels may beachieved)higher plasma levels may be

    achieved; lower dosage may be

    adequate);lactation,pregnancy,pulmonaryhypertension

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    30/44

    Name ofdrug

    Generic

    (Brand)

    Classification Dose/Frequency/

    Route

    Mechanism ofaction

    Indication Contraindication Nursing precaution

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    31/44

    Name ofdrug

    Generic

    (Brand)

    Classification Dose/Frequency/

    Route

    Mechanism ofaction

    Indication Contraindication Nursing precaution

    Nifedipine Antianginal,

    Antihypertensive,Calcium channel

    blocker.

    30 mg 1 tab,

    OD

    Inhibits the

    movement ofcalcium ions

    across themembranes of

    cardiac andarterial muscle

    cells; inhibition

    oftransmembrane

    calcium flowresults in the

    depression of

    impulseformation in

    specializedcardiac

    pacemaker cells,in slowing of the

    velocity of

    conduction ofthe cardiac

    impulse, in thedepression of

    myocardial

    contractility, andcardiac work,

    decreasedcardiac energy

    consumption,and increased

    delivery of

    oxygen tomyocardial cells.

    Angina pectoris due

    to coronary arteryspasm(Prinzmetals

    variant angina)

    Chronic stableangina (effort-

    associated angina)

    Treatment of

    hypertension

    Unlabeled uses:

    Anal fissures,urethral stones,

    topical use toimprove wound

    healing, preventionof migraine,

    Reynaud

    phenomenon.

    Contraindicated

    with allergy tonifedipine.

    Use cautiously with

    lactation, pregnancy,HF, aortic stenosis.

    Allergy to

    nifedipine,pregnancy,Lactation.

    Skin lesions, color,Edema; orientation,

    reflexes;P,BP,baselineECG,auscultation;R,

    Adventitious sounds.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    32/44

    OTHER MEDS. GIVEN:

    Name of

    drugGeneric

    (Brand)

    Classification Dose/

    Frequency/Route

    Mechanism of

    action

    Indication Contraindication Nursing precaution

    Tramadol Analgesic 1 tab 3x day

    for 5 days,PO

    Unknown;

    Certainly actingsynthetic analgesic

    Compound not

    Chemically relatedTo opioids that is

    thought to bind toopioids receptors

    and inhibit

    reuptake to norepinephrine and

    serotonin.

    Moderate-to-

    moderately severepain.

    Contraindicated

    in patientshypersensitive to

    drug and in those

    with acuteintoxication from

    alcohol,hypnotics,

    centrally acting

    analgesics,opioids, or

    psychotropicdrugs.

    Use cautiously in

    patients at risk forseizures or

    respiratory

    depression; patientswith increased

    intracranialpressure or head

    injury, acute

    abdominalconditions, or renal

    hepatic impairment;and patients

    physicallydependent on

    opioids.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    33/44

    Name of

    drugGeneric

    (Brand)

    Classification Dose/

    Frequency/Route

    Mechanism

    of action

    Indication Contraindication Nursing precaution

    Clindamycin Lincosamide

    antibiotic

    300mg cup

    3x day for7 days

    Inhibits

    proteinsynthesis in

    susceptiblebacteria,causing cell

    death.

    Topical

    dermatologicsolution:

    Treatment ofacne vulgaris.

    Systemicadministration:

    Serious

    infectionscaused by

    susceptiblestrains of

    anaerobes,streptococci,

    staphylococci,

    pneumococci;

    reserve use forpenicillin isinappropriate;

    less toxic

    antibiotics(erythromycin)

    should beconsidered.

    Vaginal

    Contraindicated with

    allergy toclindamycin,

    lactation.

    Use caution with history of

    regional enteritis or ulcerativecolitis; history of antibiotic

    associated colitis.

    Allergy to clindamycin, history

    of asthma or other allergies,hepatic or renal impairment;

    lactation; history of antibiotic-

    associated colitis.

    Site of infection or acne; skincolor,lesions;BP,R,adveventitous

    sounds; bowelsounds,output,liver evaluation;

    complete blood

    count,LFTs,renal function tests

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    34/44

    preparation:

    Treatment ofbacterial

    vaginosis.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    35/44

    VII. IDEAL TREA

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    36/44

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    37/44

    DATA NURSING

    Diagnosis

    OBJECTIVES NURSING

    INTERVENTIONS

    RATIONALE EVALUATION

    Ineffective tissue

    perfusionrelated to

    vasoconstriction of blood

    vessels

    After 8 hours of

    nursingintervention

    s, thepatient will

    be able tomaintain

    normal

    blood

    pressure.

    INDEPENDENT:

    1. Support bed rest

    2. Monitor maternal

    well being. Take bloodpressure frequently.

    3. Monitor output byinserting urinary

    catheter; and measureurinary proteins and

    specific gravity

    4. Support a nutritiousdiet

    Bed rest provide, relaxation tothe patient, and it prevents from

    any stress that may trigger to

    increase the patients bloodpressure

    To detect any increase, which is

    a warning that patientscondition is worsening

    To allow accurate recording ofoutput and comparison with

    intake; urinary output should bemore than 600mL/24hrs

    (>30mL/hr). A 24hr urine

    sample may be collected toevaluate kidney function; mild

    pre-eclampsia 0.5g

    protein/24hrs , and severe

    pre-eclampsia 5g/24hrs

    Patient needs a diet moderate to

    high in protein and moderate in

    sodium to compensate for theprotein lost in the urine.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    38/44

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    39/44

    Advised patient to have adequate sleep (6-8 hours).

    Refrain doing strenuous activities like lifting heavy objects such as fetching

    water.

    Advised client to take her medications regularly.

    Implement ROM exercises

    Eat nu t r i t i ous f oods e s pec i a l l y t hos e l ow i n f a t and s od i um

    such as fruits, milk and vegetables.

    Health Teachings

    MEDICATION:

    Continue taking medications which includes the following:

    Nifedifine 30mg 1 tab OD

    Ascorbic acid 1 tab OD

    Multi. Vitamins + Fe 1 tab OD (Supplement)

    Clindamycin 300mg 1 cap 3days (Antibiotic for pain , for 7 days)

    Tramadol w/ Paracetamo 1 tab 3x day for 5days

    EXERCISE:

    Do Activities of Daily Living (ADLs) as tolerated.

    Instructed the client to limit the ascending stairs for at least first week after

    delivery at home.

    Instructed the client to avoid strenuous activities and practice deep breathing

    exercise

    TREATMENT:

    Do daily dressing at home and follow-up after 1 week at OPD

    Advised client to monitor blood pressure

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    40/44

    Instructed patient to take prescribe medications

    Instructed the patient to take a bath everyday

    Educated patient on expected lochial discharge.

    OUT-PATIENT:

    Instructed the client to go on follow-up check-ups

    Recommended client to attend counseling seminars to assist her in coping

    with her daily life

    DIET:

    Instructed the patient to take a balance diet w/ high protein, low fat, and low

    sodium.

    Instructed the patient to increase fluid intake.

    X. DOCTORS ORDER

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    41/44

    DATE DOCTORS ORDERS RATIONALE

    January 27, 20135:00 PM

    8:00 PM

    10:00 PM

    10:45 PM

    Admit under OB

    NPO

    TPR q 4* hr.

    Secure consent

    Labs CBC, UA, HBSAG,

    BLOOD TYPE, stat

    Start IV; D5LR 1L @ 30

    gtts/min To Labor Room

    FHT q hourly

    Refer accordingly

    Hydralazine 10 mg IVTTnow

    Start hydralazine drip D5W

    250 cc + 2 days form @ 20gtts/ min

    BP q 30*min, refer it >

    160/100

    Monitor FHT

    Schedule for E CS

    Refer for OR andAnesthesia

    Secure 1 u FBC for OR

    use

    Ampicillin 1g IVTT, must

    give once q 6* h

    Insert FBC attached toUrobag

    -To monitor patient

    condition and to identify

    some problems regarding tothe mother and fetal health

    before and after delivery.

    -To prepare the GI tract

    -To monitor anyabnormalities within the

    hospital admission

    -For the patient to be awarefor any actions that may be

    performed while she is in

    the ward-To find out if there are

    abnormal findings

    regarding the patient.

    -To balance fluid volume in

    the body

    -To prepare the patient fordelivery.

    -To monitor heart rate

    activity of the fetus.-To report any unusualities

    and complications during

    labor will happen.-Reduces BP mainly by

    direct effect on vascular

    smooth muscles or arterial

    resistance vessels, resultingin vasodilation.

    -To prevent increase of BP

    -To monitor the rising of

    blood pressure and to

    anticipate actions.

    -To deliver the baby as

    soon and as safe as possible

    -To prepare the patient for

    cesarean section

    - to prepare patient for

    cesarian section

    - Prophylaxis in cesarean

    section-To monitor the patient

    output

    -To prepare patient foroperation.

    -To prepare patient for

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    42/44

    XI. PROGNOSIS

    The outlook for full recovery from preeclampsia is very good. Most women begin to

    improve within one to two days after delivery, and blood pressure returns to the normal

    pre-pregnancy range within the next 6 to 12 weeks. Prenatal care can dramatically reduce

    the complications and deaths of preeclampsia, because women who are diagnosed while

    preeclampsia is mild can receive treatment without any delay. Between 5% and 8% of

    pregnant women in the United States develop preeclampsia. Progress in treating

    eclampsia has saved the lives of both mothers and their newborns. In the United States

    and Britain, between 1% and 2% of women who developed eclampsia die and 3% of their

    babies die during or shortly after birth. The maternal death rate from eclampsia in

    locations where health care is not easily available can exceed 13%.

    Risks to the fetus from preeclampsia include intrauterine growth retardation and lowbirth weight, placental abruption, and stillbirth. The fetus may be delivered prematurely if

    the condition of the mother deteriorates. Risks to the mother include vascular organdamage; the additional risks of eclampsia include convulsions and accompanying oxygen

    deprivation, hemorrhage in the brain, temporary blindness, permanent neurological

    damage, liver or kidney damage, cerebrovascular and cardiovascular complications, andeven death. The prognoses for both the fetus and mother are excellent in mild

    preeclampsia. If blood pressure readings are within normal limits after several weeks

    postpartum, the mother may still be at increased risk of hypertension later in life, and

    should have her blood pressure checked yearly.

    The long-term prognosis for children born to preeclamptic mothers is not yet known.These individuals do, however, appear to be at increased risk of chronic disease in adult

    life. Sign and symptoms of preeclampsia usually go away within 6 weeks after delivery.However, the high blood pressure sometimes gets worse the first few days after delivery.

    If you have had preeclampsia, you are more likely to develop it again in another

    pregnancy. However, it is not usually as severe as the first time. If you have high blood

    pressure during more than one pregnancy, you are more likely to have high bloodpressure when you get older.

    XII. RESEARCH UPDATE

    RESEARCH UPDATES

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    43/44

    One in 20 Cases of Pre-Eclampsia May Be Linked to Air Pollutant

    Feb. 6, 2013 One in every 20 cases of the serious condition of pregnancy, pre-eclampsia, may be linked to increased levels of the air pollutant ozone during the first

    three months, suggests a large study published in the online journal BMJ Open.

    Mothers with asthma may be more vulnerable, the findings indicate. Thousands ofwomen and babies die or get very sick each year from a dangerous condition called

    preeclampsia, a life-threatening disorder that occurs only during pregnancy and the

    postpartum period. Preeclampsia and related disorders such as HELLP syndrome and

    eclampsia are most often characterized by a rapid rise in blood pressure that can lead toseizure, stroke, multiple organ failure and death of the mother and/or baby.

    Pre-eclampsia is characterised by raised blood pressure and the presence of protein in the

    urine during pregnancy. It can cause serious complications, if left untreated.

    The authors base their findings on almost 121,000 singleton births in Greater Stockholm,Sweden, between 1998 and 2006; national data on the prevalence of asthma among the

    children's mothers; and levels of the air pollutants ozone and vehicle exhaust (nitrogen

    oxide) in the Stockholm area.

    There's a growing body of evidence pointing to a link between air pollution andpremature birth, say the authors, while pregnant women with asthma are more likely to

    have pregnancy complications, including underweight babies and pre-eclampsia.

    In all, 4.4% of the pregnancies resulted in a premature birth and the prevalence of pre-

    eclampsia was 2.7%.

    There was no association between exposure to levels of vehicle exhaust and

    complications of pregnancy, nor were any associations found for any air pollutants and

    babies that were underweight at birth.

    But there did seem to be a link between exposure to ozone levels during the first threemonths of pregnancy and the risk of premature birth (delivery before 37 weeks) and pre-

    eclampsia, after adjusting for factors likely to influence the results and seasonal

    variations in air pollutants, although not spatial variations in exposure.

    Each rose by 4% for every 10 ug/m3 rise in ambient ozone during this period, the

    analysis indicated.

    XIII. REFEERENCES

    Pilliteri, Adele.

  • 7/28/2019 CP FINAL-- Pre-eclampsia

    44/44

    Maternal and Child Health Nursing: Care of the childbearing and childrearing

    family/Adele Pilliteri. 6th edition. Copyright 2010 Lippincott Williams & Wilkins.

    ISBN 9781451108798

    Marieb, Elaine.

    Essentials of Human Anatomy and Physiology, 7 th edition by Marieb, Elaine N.,

    Published by Pearson Education Inc., Copyright 2003. San Francisco, CA 94111 Original

    ISBN 0805353860

    Doenges, Marilynn

    Nursing care plans : guidelines for individualizing client care/ Marilynn E.

    Doenges, Mary Frances Moorhouse, Alice C. Murr.-Ed. 7. ISBN 080361294X. Copyright

    2006 by F.A. Davis Company

    Wilson, Billie Ann

    Prentice Halls Nurses Drug Guide 2004, 1st Edition by Wilson, Billie Ann;

    Shannon, Margaret, Stang, Carolyn. Published by Pearson Education Inc. Copyright 2004

    Doenges, Marilynn

    Nurses Pocket Guide : Diagnoses, Prioritized Interventions, and Rationales/

    Marilynn E. Doenges, Mary Frances Moorhouse, Alice C. Murr.-Ed. 7. ISBN

    9789746520423. Copyright 2008 by F.A. Davis Company